These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33500197)

  • 1. Point-of-care C-reactive protein testing to support the management of respiratory tract infections in community pharmacy: A feasibility study.
    Sim TF; Chalmers L; Czarniak P; Hughes J; Iacob R; Lee YP; Parsons K; Parsons R; Sunderland B
    Res Social Adm Pharm; 2021 Oct; 17(10):1719-1726. PubMed ID: 33500197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care C-reactive protein testing service for respiratory tract infections in community pharmacy: a qualitative study of service uptake and experience of pharmacists.
    Czarniak P; Chalmers L; Hughes J; Iacob R; Lee YP; Parsons K; Parsons R; Sunderland B; Sim TF
    Int J Clin Pharm; 2022 Apr; 44(2):466-479. PubMed ID: 35088232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation factor mapping of a pilot study of point-of-care C-reactive protein testing for respiratory tract infections in community pharmacy.
    Chalmers L; Czarniak P; Hughes J; Iacob R; Lee YP; Parsons K; Parsons R; Sunderland B; Sim TF
    Explor Res Clin Soc Pharm; 2022 Jun; 6():100147. PubMed ID: 35733607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein point of care testing in community pharmacy: Observational study of a Northern Ireland pilot.
    O'Neill K; Fleming G; Scott M; Plant G; Varma S
    Pharm Pract (Granada); 2022; 20(4):2711. PubMed ID: 36793914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Acceptability and Willingness-to-pay for a C-reactive Protein Point-of-care Testing Service to Improve Antibiotic Dispensing for Respiratory Infections in Vietnamese Pharmacies: A Mixed-methods Study.
    Vinh Nguyen N; Do NTT; Vu HTL; Bui PB; Pham TQ; Khuong VT; Lai AT; van Doorn HR; Lewycka SO
    Open Forum Infect Dis; 2024 Aug; 11(8):ofae445. PubMed ID: 39192993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility, accessibility and acceptability a pharmacist-led ear health intervention at rural community pharmacies (LISTEN UP): a mixed-methods study in Queensland, Australia.
    Taylor S; Cairns A; Glass BD
    BMJ Open; 2022 Apr; 12(4):e057011. PubMed ID: 35365533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What a difference a CRP makes. A prospective observational study on how point-of-care C-reactive protein testing influences antibiotic prescription for respiratory tract infections in Swedish primary health care.
    Lindström J; Nordeman L; Hagström B
    Scand J Prim Health Care; 2015; 33(4):275-82. PubMed ID: 26643196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of point-of-care C-reactive protein testing intervention on non-prescription dispensing of antibiotics for respiratory tract infections in private community pharmacies in Nigeria: a cluster randomized controlled trial.
    Onwunduba A; Ekwunife O; Onyilogwu E
    Int J Infect Dis; 2023 Feb; 127():137-143. PubMed ID: 36509332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein point-of-care testing and associated antibiotic prescribing.
    Minnaard MC; van de Pol AC; Hopstaken RM; van Delft S; Broekhuizen BD; Verheij TJ; de Wit NJ
    Fam Pract; 2016 Aug; 33(4):408-13. PubMed ID: 27230745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study.
    Kelly DV; Kielly J; Hughes C; Gahagan J; Asghari S; Hancock S; Burt K; Smyczek P; Charlton C; Nguyen H
    BMC Public Health; 2020 May; 20(1):639. PubMed ID: 32380978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist's Demand for Optimal Primary Care Service Delivery in a Community Pharmacy: The OPTiPharm Study.
    Munger MA; Walsh M; Godin J; Feehan M
    Ann Pharmacother; 2017 Dec; 51(12):1069-1076. PubMed ID: 28737045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies.
    Huang Y; Chen R; Wu T; Wei X; Guo A
    Br J Gen Pract; 2013 Nov; 63(616):e787-94. PubMed ID: 24267862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards the implementation of breastfeeding-related health services in community pharmacies: Pharmacists' perspectives.
    Sim TF; Hattingh HL; Sherriff J; Tee LBG
    Res Social Adm Pharm; 2017; 13(5):980-988. PubMed ID: 28325528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community pharmacist-directed point-of-care group A Streptococcus testing: Evaluation of a Canadian program.
    Papastergiou J; Trieu CR; Saltmarche D; Diamantouros A
    J Am Pharm Assoc (2003); 2018; 58(4):450-456. PubMed ID: 29681440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project.
    Dong BJ; Lopez M; Cocohoba J
    J Am Pharm Assoc (2003); 2017; 57(4):510-515.e2. PubMed ID: 28602784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the impact of influenza and streptococcus point-of-care testing and collaborative practice prescribing in a community pharmacy setting.
    Kirby J; Mousa N
    J Am Pharm Assoc (2003); 2020; 60(3S):S70-S75. PubMed ID: 32253085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring oral healthcare management across Australian community pharmacies using case vignettes.
    Taing MW; Firth N; Ford PJ; Freeman CR
    Community Dent Oral Epidemiol; 2019 Jun; 47(3):225-235. PubMed ID: 30734359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
    Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
    J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
    Krska J; Mackridge AJ
    Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.